Targeting EP2/EP4-driven expansion of suppressive VSIG4high macrophages overcomes immunotherapy resistance in colorectal cancer
Cell Reports · 2026-06 · 45 (6) · 117450
DOI: 10.1016/j.celrep.2026.117450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-06. Verfasst von Yao Zhang und 25 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Discovery & Translational Medicine, Hainan Academy of Medical Sciences, Hainan Medical University, Haikou, Hainan, China; Engineering…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Receptors, Prostaglandin E, EP4 Subtype, Receptors, Prostaglandin E, EP2 Subtype, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, NIH National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Drug Discovery & Translational Medicine, Hainan Academy of Medical Sciences, Hainan Medical University, Haikou, Hainan, China; Engineering Research Center of Tropical Medicine Innovation and Transformation of…
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
- Department of General Surgery and Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Urology and Department of Pathology, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.
- Department of Colorectal Surgery, Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- NIH National Cancer Institute
- National Science and Technology Major Project
- Zhejiang University
- National Institutes of Health
Zitieren
APA
Zhang, Y., Yang, X., Cheng, Z., He, M., He, J., Wang, W., Quan, K., Ma, S., Wu, J., Chai, X., Abuduaini, N., Feng, B., Rui, W., Wang, Y., Wu, J., Li, D., Li, G., Du, L., Wang, M., …, & Lu, W. (2026). Targeting EP2/EP4-driven expansion of suppressive VSIG4high macrophages overcomes immunotherapy resistance in colorectal cancer. Cell Reports, 45(6), 117450. https://doi.org/10.1016/j.celrep.2026.117450
Vancouver
Zhang Y, Yang X, Cheng Z, He M, He J, Wang W, et al. Targeting EP2/EP4-driven expansion of suppressive VSIG4high macrophages overcomes immunotherapy resistance in colorectal cancer. Cell Reports. 2026;45(6):117450. doi:10.1016/j.celrep.2026.117450
BibTeX
@article{Zhang2026,
author = {Zhang, Yao and Yang, Xinyu and Cheng, Zhiyuan and He, Mengxian and He, Jiacheng and Wang, Wei and Quan, Ke and Ma, Siqi and Wu, Jun and Chai, Xiaolei and Abuduaini, Naijipu and Feng, Bo and Rui, Weiwei and Wang, Yang and Wu, Jingbo and Li, Dawei and Li, Guichao and Du, Limin and Wang, Mengru and Yang, Linlin and Zhu, Ning and Nussinov, Ruth and Cheng, Feixiong and Ballestar, Esteban and Liu, Mingyao and Lu, Weiqiang},
title = {Targeting EP2/EP4-driven expansion of suppressive VSIG4high macrophages overcomes immunotherapy resistance in colorectal cancer},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {6},
pages = {117450},
doi = {10.1016/j.celrep.2026.117450}
}
EUVIMED